AdJane Biosciences ("AdJane"), a clinical-stage next-generation vaccine platform company that focuses on enabling the development of scalable multivalent vaccines that induce both systemic and mucosal ...
Lassa Fever and Diphtheria should be footnotes in Nigeria’s public health history. Instead, they remain headlines. A rat in ...
The X-Men reboot film is expected to be released on May 5, 2028, and casting has been underway for quite some time.
Rezubio has dosed the first cohort of patients in a Phase I trial of RZ-520, an inhaled therapeutic drug for chronic respiratory diseases. The study follows investigational new drug clearances (IND) ...
Rezubio gets US FDA & Chinese NMPA clearances and first cohort dosing of RZ-520, a novel inhaled therapy for chronic respiratory diseases: Zhuhai, China Tuesday, September 8, 2026 ...
ZHUHAI, China, Sept. 06, 2026 (GLOBE NEWSWIRE) -- Rezubio today announced that it has successfully completed dosing of the first cohort in its Phase 1 clinical trial following clearances from the US ...
Microplastic contamination in biological systems is becoming a significant concern in environmental and biomedical studies.
New whole blood RNA sequencing data identified coordinated, consistent change in genes governing immune re-balancing, myofibroblast inhibition, ...
Kansas animal health officials discuss New World screwworm and theileria threats facing cattle producers at the recent Crops ...
Getting ready for the fall and winter respiratory virus season can raise questions about immunizations you might need, when ...
The Modesto Bee on MSN
How new procedure at Modesto hospital helps people with severe lung disease
Valve device replacement is not a miracle procedure but aims to improve quality of life for people with debilitating lung disease.
GRI Bio, Inc. announced new Phase 2a data from its GRI-0621-IPF-02 study evaluating oral GRI-0621 in patients with idiopathic pulmonary fibrosis (IPF). The data, presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results